There are plenty of reasons to receive an extension to the CR response deadline, including an inability to obtain reference product samples for bioequivalence testing. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
